AORTIC ANEURYSM MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025 - 2032)

Global Aortic Aneurysm Market Size and Forecast – 2025 to 2032

The Global Aortic Aneurysm Market is estimated to be valued at USD 4.94 Bn in 2025 and is expected to reach USD 11.27 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 12.5% from 2025 to 2032. This substantial growth reflects the increasing prevalence of aortic aneurysms worldwide, advancements in diagnostic and treatment technologies, and rising awareness among healthcare providers and patients. Expanding elderly population and improved healthcare infrastructure also contribute significantly to the market expansion.

Key Takeaways of the Global Aortic Aneurysm Market

• Abdominal Aortic Aneurysm is expected to account for the largest share of the global aortic aneurysm market at 45.3% in 2025.
• Open Surgical Repair remains the dominant treatment type, representing an estimated 65.8 share in 2025.
• Among product categories, stent grafts are expected to lead the market with a 34.5% share in 2025.
• North America is expected to lead the market, holding a share of 38.3% in 2025.
• Asia Pacific is anticipated to be the fastest-growing region, with a market share of 24.5% in 2025.

Market Overview

A prominent trend in the aortic aneurysm market is the rising adoption of minimally invasive endovascular procedures over traditional open surgeries. Innovations in stent grafts, imaging technologies, and patient monitoring devices are enhancing procedural safety and outcomes, driving demand. Additionally, growing investments in research and development by key players to improve device efficacy and reduce complications are expected to shape the competitive landscape. Furthermore, increasing healthcare expenditure in emerging economies is facilitating greater access to advanced treatment options, fueling sustained market growth.

Current Events and Its Impact

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Segmental Insights

To learn more about this report, Download Free Sample

Aortic Aneurysm Market Insights, By Aneurysm Location - Abdominal Aortic Aneurysm contributes the highest market share owing to the high prevalence and clinical urgency associated with this condition

In 2025, Abdominal Aortic Aneurysm is expected to dominate the market with 45.3% share, as AAA occurs more frequently than aneurysms in other sites. AAA, which is a subclass of aortic aneurysm, is generally formed below the renal arteries in the aorta's abdominal section. It is often associated with the risk factors of aging populations, atherosclerosis, smoking, and hypertension, which are becoming more common globally.

Since the rupture of AAA is the only way to make them symptomatic, regular screening has become a necessity. Thus, a new line of cases for early diagnosis and treatment effective solutions has opened up. In addition, the complicated and high-risk nature of thoracic aneurysms has made abdominal aortic therapeutic condition more comfortable and very accessible, especially when it concerns endovascular repairs, which are the least invasive method.

Aortic Aneurysm Market Insights, By Treatment Type – Open Surgical Repair maintains the highest market share due to its established efficacy and broad applicability across patient profiles

Open Surgical Repair remains the primary treatment of choice for aortic aneurysms accounting for a projected 65.8% in 2025. Although the adoption of endovascular interventions, which are less invasive, is on the rise, in many clinical case scenarios, open repair is still considered the most durable less-invasive approach. It is also the most thorough treatment in the aspects of both addressing and managing the complex aneurysm.

One of the key factors contributing to the ongoing superiority of open surgical repair is its adaptability to patients who are anatomically inappropriate for endovascular procedures. This includes patients with large or kinked aneurysms or those with an aortic neck that is not conducive for stent graft anchoring. In such situations, open repair guarantees the same superior exclusion of the aneurysm sac and this comes with even lesser risk of secondary interventions

Aortic Aneurysm Market Insights, By Product Type – Stent Grafts dominate the market, propelled by advancements in device technology and expanding indications for endovascular aneurysm repair

Stent Grafts play a leading role in less invasive surgical techniques, especially in the case of endovascular aneurysm repair (EVAR), accounting for an expected 34.5% market share in 2025. These devices have significantly changed the way aneurysms are treated by providing open surgery as the only alternative, thus allowing the patient to recuperate quickly and lessening the risks associated with the procedure.

In May 2021, Endologix LLC, a global vascular device company, launched its ALTO Abdominal Stent Graft in Canada and Argentina. The ALTO system is a next-generation EVAR technology for Abdominal Aortic Aneurysm patients. It uses a patented sealing ring that adapts to each aortic neck. The first Canadian medical implant occurred on May 4 in Quebec.

Disease Prevalence and Screening Gaps by Aneurysm Type (AAA vs TAA)

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Regional Insights

To learn more about this report, Download Free Sample

North America Aortic Aneurysm Market Analysis and Trends

The North American region holds the largest share in the global aortic aneurysm market, accounting for 38.3% in 2025. This is primarily due to its well-established healthcare infrastructure, high incidence of cardiovascular diseases, and significant funding for medical research and technology.

Moreover, the presence of global giants such as Medtronic, Abbott Laboratories, and Boston Scientific strengthens the research and development particularly in the area of less invasive devices and imaging technologies that are essential for the detection and treatment of aneurysms. Governments' favorable policies that support healthcare innovation and cover the costs of new therapies also play a role in the wider acceptance of advanced treatment options.

Asia Pacific Aortic Aneurysm Market Analysis and Trends

The Asia Pacific market for aortic aneurysms, with an estimated 24.5% of its total value in 2025, witnesses the fastest growing demand. This is attributed to developing healthcare infrastructure, the rising number of patients with cardiovascular diseases, and increased government attention to chronic disease management.

China, Japan, and India are heavily investing in the modernization of their healthcare systems with advanced diagnosis and surgical equipment. The main demand drivers are the growing elderly population and better insurance coverage. Manufacturers such as Terumo Corporation and W. L. Gore & Associates, among others, are gaining their footholds in this market by means of strategic alliances and local production.

Aortic Aneurysm Market Outlook for Key Countries:

U.S. Aortic Aneurysm Market Trends

The aortic aneurysm market in the U.S. is very progressive. It is primarily due to the large investment in healthcare and favorable regulatory conditions that promote new product development. Medtronic and Abbott, among others, have developed the most sophisticated endovascular stent grafts, which have completely changed the approach to aneurysm treatment. Extensive clinical research, along with great public awareness, is leading to the quick diagnosis and active management of patients.

For Example, Cook Medical offers its Zenith portfolio of endovascular grafts for both abdominal and thoracic aortic aneurysm repair in the U.S. moreover, Endologix LLC focused on minimally invasive endovascular repair systems like the ALTO abdominal stent graft for infrarenal aortic aneurysms

Germany Aortic Aneurysm Market Trends

The aortic aneurysm market in Germany is expected to grow gradually, as innovative endovascular repair techniques will be more widely used. The support of a well-established healthcare system will also allow for early diagnosis and intervention.

In July 2022, Bentley InnoMed advanced clinical evidence by completing 100 patient enrollments in Germany for its BGP Stent as Bridging Stent in FEVAR trial, evaluating the durability and performance of the BeGraft balloon-expandable covered stent in complex aortic aneurysm repair.

Japan Aortic Aneurysm Market Trends

In Japan, the demand for aortic aneurysm treatment is still the highest thanks to the advanced medical technology infrastructure and a growing aging population with increasing cardiovascular risk. The efforts of local companies like Terumo Corporation help create an innovative treatment solution alongside international corporations. The government’s focus on preventive care and reimbursement schemes makes the adoption of early screening and non-invasive treatment possible.

In July 2023, Terumo Aortic, a global aortic repair company, received the pharmaceuticals and medical devices agency approval in Japan for its Thoraflex Hybrid device used in complex Aortic Aneurysm and dissection repair. The hybrid graft combines a polyester tube and self-expanding stent to treat the aortic arch and descending aorta. Terumo said the approval expands its surgical and endovascular portfolio in Japan, where Thoraflex will support its strategy of providing solutions for every aorta.

China Aortic Aneurysm Market Trends

The aortic aneurysm market in China is changing very fast. Access to healthcare is getting better and government programs for chronic disease control are being the main drivers of this change. Urban population growth and better health awareness are the main factors creating the need for endovascular aneurysm repair devices in the country. The collaboration between the international companies like W. L. Gore & Associates and local manufacturers not only increases product availability but also makes it possible for more people to buy the products.

In March 2025, Chinese researchers announced a breakthrough experimental vaccine that prevents arterial plaque buildup, potentially reducing heart attacks, strokes, and aortic aneurysm risk. The nanovaccine, published in Nature, uses a p210 antigen linked to iron oxide nanoparticles to trigger an immune response that slows atherosclerosis progression. In mouse studies, it prevented plaque growth even on a high-cholesterol diet.

Market Players, Key Developments, and Competitive Intelligence

To learn more about this report, Download Free Sample

Key Developments

• In September 2025, Ontario Health launched the first Abdominal Aortic Aneurysm Screening Program in Canada, offering free ultrasound screening to adults beginning at age 65 to enable early detection and prevent deadly ruptures. Eligible Ontarians will receive mailed invitations, with expansion planned to include ages 65–80 by spring 2026 and a self-referral option to ultrasound labs.
• In June 2025, Aortic Dissection Awareness UK & Ireland, a national patient charity improving Aortic Aneurysm awareness, launched a new British Cardiovascular Society-endorsed leaflet titled Understanding Thoracic Aortic Aneurysm to help patients and families understand diagnosis, risks, monitoring, and lifestyle guidance.
• In March 2024, UC Davis Health began the region’s first clinical trial using a physician-sponsored FDA investigational device exemption to treat complex aortic aneurysms with customized endovascular grafts. Vascular surgeon Steven Maximus received approval as one of only 18 U.S. surgeons allowed to test the device, and the only one in Northern California.
• In August 2024, Terumo India launched TREO stent-graft, the only EVAR system with both suprarenal and infrarenal active fixation, offering adjustable limb design and improved sealing for complex infrarenal abdominal aortic aneurysms. Terumo executives said the device reduces migration and re-intervention risk while addressing India’s growing need for advanced endovascular solutions.

Top Strategies Followed by Global Aortic Aneurysm Market Players

• The market leaders invest heavily in research and development to create high-quality products that satisfy both doctors and patients. The development of next-generation stent grafts and minimally invasive devices to enhance outcomes and efficiency, along with the forming of strategic alliances with important OEMs to expand product ranges and improve supply chains, are the areas of focus for these companies.
  • For instance, Medtronic, Cook Medical, and Gore Medical are the three main players in the aortic aneurysm market. Medtronic's leading position is attributed to its the Endurant II/IIs and Valiant Navion stent graft systems, which are backed with strong R&D and global surgeon training programs. Gore’s Excluder AAA and Cook’s Zenith platforms not only support their leadership through long-standing clinical data, OEM associations, and strong hospital distribution networks, but they also help in their leadership.

• The mid-tier players in the aortic aneurysm market take a rather different and diverse but also supportive approach by focusing on the production of low-priced items that have the right quality and price ratio. These companies mainly focus on the healthcare providers and patients in developing regions who are not willing to pay high-priced items. Companies that want to remain competitive invest in the improvement of manufacturing processes and the procurement of low-priced materials that do not affect product performance.
  • For instance, Endologix, Terumo Aortic, and Lombard Medical are the innovators with a focus on cost and provide EVAR/TEVAR devices that are inexpensive and at the same time reliable. Endologix AFX2 system and Terumo Aortic Anaconda platform are specifically looking at the price-sensitive markets of Asia Pacific, Latin America, and Eastern Europe. These companies are always reducing costs in manufacturing but at the same time ensuring that the products perform at the prescribed levels of the market.

• Small companies find their way through the competition by making a niche for themselves and focusing on the core features and technologies that are the best. These new innovations, for example, bioengineered materials, customized grafts, and smart digitally integrated devices for niche clinical needs, are some of the ways that these companies are differentiated. Moreover, they also advanced in manufacturing like using 3D printing and precision engineering to remain competitive against bigger players.
  • Moreover, Jotec (which has now been taken over by CryoLife), Relievant, and Cardiatis are examples of companies that work in the advanced stent graft designs, biomaterial-based vascular implants, and multi-layer flow modulator technology. The multilayer stents of Cardiatis and the custom grafts of Jotec made using precision engineering and 3D customization are examples of how smaller companies compete through specialization and disruptive technology instead of merely through scaling.

Market Report Scope

Aortic Aneurysm Market Report Coverage

Aortic Aneurysm Market Dynamics

To learn more about this report, Download Free Sample

Aortic Aneurysm Market Driver - Rising prevalence of aortic aneurysm in aging population

One of the major factors that is driving the global aortic aneurysm market growth is the high incidence rate of aortic aneurysm in the elderly. When the average lifespan of a person keeps increasing around the globe, more and more people will be getting into the age groups that are most prone to aortic aneurysms, especially those above 65 years old. Aging is leading to the gradual softening of the aortic wall which is a result of natural degenerative processes like the reduction in the amounts of elastin and collagen, hence giving rise to a higher risk of aneurysm formation. Furthermore, the elderly population usually has accompanying diseases like high blood pressure, hardening of the arteries, and other heart problems that increase the chances of aneurysm development further.

For instance, in August 2025, Karolinska Institutet reported new Aortic Aneurysm prevalence data from a 14-year screening of 117120 Swedish men. AAA prevalence dropped from 1.32% to 0.69%, while sub-aneurysmal aortas declined from 1.53% to 0.77%. Small aortas rose from 18.5% to 21.9%, creating a new high-risk group. Men with small or aneurysmal aortas showed 1.5 to 2.5 times higher five-year mortality than those with normal aortic size. Smoking remained the strongest modifiable risk factor, and quitting smoking reduced aneurysm growth, delayed surgery, and improved survival. The Swedish Heart Lung Foundation funded the research with regional support.

Aortic Aneurysm Market Opportunity - Advancements in Artificial Intelligence for Diagnosis and Monitoring

Adoption of artificial intelligence (AI) in the diagnosis and follow-up of aortic aneurysms is considered a significant opportunity for the global aortic aneurysm market to grow. AI-powered imaging technologies and predictive analytics are changing the way doctors detect and treat aortic aneurysms by improving diagnosis accuracy and allowing for earlier detection. Machine learning algorithms can process enormous quantities of medical imaging data including CT scans, MRIs, and ultrasounds much faster and more accurately than the conventional techniques that they reduce the chances of human mistakes and at the same time, they improve the quality of patient care. In addition, the predictive models that drive the AI assess risk factors and disease progression, and thus, provide personalized monitoring schedules that are aimed at preventing aneurysm rupture which is a life-threatening event.

For instance, in November 2024, Nurea, a France-based AI medical imaging company, received the U.S. FDA clearance for its PRAEVAorta2 software for Aortic Aneurysm care. The platform offers automated aortic diameter measurement on CT scans and supports diagnosis and follow-up. Nurea says it helps identify surgery candidates faster and prevents patient loss during surveillance. Aortic Aneurysm remains the tenth leading cause of death in men over 55 in the U.S.

Analyst Opinion (Expert Opinion)

• The aortic aneurysm market is growing at a faster pace because of the aging populations and the increased cardiovascular risk which in turn is expanding the treatment base. In numerous medical centers, EVAR and TEVAR have become the norm, and the combination of new branched/fenestrated grafts, advanced imaging, and planning tools is making it possible to treat even the most complex cases. The patient population being diagnosed is steadily growing as a result of the screening programs and the updating of guidelines, but the overall market growth is being limited due to the high cost of devices, requirement for evidence from the payers, and shortage of skilled endovascular teams.
• A small but powerful group of vascular congresses is now influencing the practices of the whole medical community by doing live cases and showing late-breaking trials. The approval of iliac branch and thoracic grafts, along with U.K. national screening and U.S. evidence-backed recommendations, are all working together to ensure extremely high procedure volumes for a long time. Strong clinical evidence, persuasive economic arguments, and extensive surgeon training and support networks are the factors that have determined which companies will dominate the competition.

Market Segmentation

• Aneurysm Location Insights (Revenue, USD Bn, 2020 - 2032)
  • Abdominal Aortic Aneurysm
  • Thoracic Aortic Aneurysm
  • Thoracoabdominal Aortic Aneurysm
• Treatment Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Open Surgical Repair
  • Endovascular Aneurysm Repair
• Product Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Stent Grafts
  • Catheters
  • Guidewires
  • Balloon Angioplasty Devices
  • Other Endovascular Accessories
• Diagnosis Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Ultrasound (Screening & Surveillance)
  • Computed Tomography Angiography (CTA)
  • Magnetic Resonance Angiography (MRA)
  • Conventional Catheter Angiography
  • Intravascular Ultrasound (IVUS)/Intraoperative Imaging
• Age Group Insights (Revenue, USD Bn, 2020 - 2032)
  • Below 60 Years
  • 60–75 Years
  • Above 75 Years
• Gender Insights (Revenue, USD Bn, 2020 - 2032)
  • Male
  • Female
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals
  • Specialty Cardiac and Vascular Centers
  • Ambulatory Surgical Centers
  • Diagnostic Imaging Centers
  • Research and Academic Institutes
• Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
  • Online
  • Offline
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Medtronic plc
  • Cook Medical LLC
  • L. Gore and Associates Inc.
  • Terumo Corporation
  • Endologix LLC
  • Cardinal Health Inc.
  • Becton Dickinson and Company (BD)
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Braun Melsungen AG
  • JOTEC GmbH (CryoLife / Artivion)
  • Lombard Medical Technologies
  • Cordis (a Cardinal Health company / Cordis Inc.)
  • Merit Medical Systems Inc.
  • LeMaitre Vascular Inc.

Sources

Primary Research Interviews

• Industry Stakeholders
  • Vascular device manufacturers
  • Hospital procurement directors
• End Users
  • Vascular surgeons
  • Hospital administrators
  • Clinical research organisations

Government and International Databases

• OECD Health Statistics
• WHO Global Health Observatory
• National health insurance databases
• Global Burden of Disease data
• National vital statistics databases
• National health ministry databases

Trade Publications

• Vascular Today
• MedTech Insight
• Interventional Cardiology Review
• Healthcare tech trade journals
• Device industry newsletters
• Regional healthcare market publications

Academic Journals

• Journal of Vascular Surgery
• European Journal of Vascular Surgery
• Vascular Medicine
• Frontiers in Cardiovascular Medicine
• Systematic reviews on aneurysm repair
• Biomechanics/imaging journals

Reputable Newspapers

• The Wall Street Journal
• The New York Times
• The Guardian
• Bloomberg Healthcare
• Reuters Health
• Nikkei Asia

Industry Associations

• European Society for Vascular Surgery
• Society for Vascular Surgery
• International Society for Endovascular Specialists
• American Heart Association
• World Heart Federation
• Regional vascular surgery associations

Public Domain Resources

• Clinical trial registries (e.g., ClinicalTrials.gov)
• Patent databases
• Government hospital reports
• Open-access datasets
• WHO/Global-Health statistics
• Open-access preprint servers

Proprietary Elements

• CMI Data Analytics Tool: Proprietary analytics tool to analyze real-time market trends, consumer behavior, and technology adoption in market
• Proprietary CMI Existing Repository of Information for Last 8 Years